Advance for Cardiovascular Health in China
- 49 Downloads
As the most populous country worldwide, China has ≈ 290 million patients with cardiovascular diseases (CVDs), representing the leading cause of death in Chinese population. The morbidity and mortality of CVDs are continuously rising. Here, we will first summarize the recent advance in the management of CVDs such as coronary arterial disease, arrhythmia, and heart failure in China. In particular, we will introduce the development of chest pain centers and indicate the novel techniques and methods applied for the management of CVDs. Then, we will discuss and point out the importance of improving the clinical and basic research for Traditional Chinese medicine in the treatment of CVDs. Finally, we will emphasize the efforts made to promote cardiac rehabilitation and cardiovascular prevention system in China. We are striving to establish a practical prevention-treatment-rehabilitation system and looking forward to a bright future with reduced morbidity and mortality from CVDs in China.
KeywordsCardiovascular diseases China Prevention Treatment Rehabilitation
This work was supported by grants from the National Natural Science Foundation of China (81722008, 91639101, and 81570362 to JJ Xiao, 81770401 to YH Bei), National Key Research and Development Program of China (2017YFC1700401 to YH Bei), Innovation Program of Shanghai Municipal Education Commission (2017-01-07-00-09-E00042 to JJ Xiao), the grant from the Science and Technology Commission of Shanghai Municipality (17010500100 to JJ Xiao), and the development fund for Shanghai talents (to JJ Xiao).
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Research Involving Human Participants and/or Animals
This article does not contain any studies with human participants or animals performed by any of the authors.
This article does not contain any studies with human participants.
- 1.Roth, G. A., Johnson, C., Abajobir, A., Abd-Allah, F., Abera, S. F., Abyu, G., et al. (2017). Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol, 70(1), 1–25.Google Scholar
- 2.National Center for Cardiovascular Diseases, China (2018). Report on Cardiovascular Diseases in China 2017. Beijing: Encyclopedia of China Publishing House.Google Scholar
- 5.Section of Interventional Cardiology of Chinese Society of Cardiology of Chinese Medical Association, Specialty Committee on Prevention and Treatment of Thrombosis of Chinese College of Cardiovascular Physicians, Editorial Board of Chinese Journal of Cardiology. (2016). Chinese guideline for percutaneous coronary intervention (2016). Chin J Cardiol, 44(5), 382–400.Google Scholar
- 8.Pu, J., Ding, S., Ge, H., Han, Y., Guo, J., Lin, R., et al. (2017). Efficacy and safety of a pharmaco-invasive strategy with half-dose alteplase versus primary angioplasty in ST-segment-elevation myocardial infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction). Circulation, 136(16), 1462–1473.CrossRefPubMedGoogle Scholar
- 13.Han, Y., Xu, B., Xu, K., Guan, C., Jing, Q., Zheng, Q., et al. (2016). Six versus 12 months of dual antiplatelet therapy after implantation of biodegradable polymer sirolimus-eluting stent: randomized substudy of the I-LOVE-IT 2 trial. Circulation. Cardiovascular Interventions, 9(2), e003145.Google Scholar
- 14.Wang, Z. Q., Qiang, H., Luo, X., Li, W., Guo, K., & Li, Y. G. (2018). Meta-analysis of risk of ventricular arrhythmias and all-cause mortality in patients with chronic total occlusion of a coronary artery and/or implantable cardioverter-defibrillator. The American Journal of Cardiology, 121(10), 1149–1154.CrossRefPubMedGoogle Scholar
- 16.Chen, Y., Zhang, Y., Huang, W., Huang, K., Xu, B., & Su, X. I. (2017). Primary and secondary stroke prevention using left atrial appendage closure with Watchman devices in atrial fibrillation patients: a single center experience from mainland China. Pacing and Clinical Electrophysiology, 40(6), 607–614.CrossRefPubMedGoogle Scholar
- 18.Huang, H., Liu, Y., Xu, Y., Wang, Z., Li, Y., Cao, K., et al. (2017). Percutaneous left atrial appendage closure with the LAmbre device for stroke prevention in atrial fibrillation: a prospective, multicenter clinical study. JACC. Cardiovascular Interventions, 10(21), 2188–2194.CrossRefPubMedGoogle Scholar
- 19.Heart Failure Group of Chinese Society of Cardiology of Chinese Medical Association, Chinese Heart Failure Association of Chinese Medical Doctor Association, Editorial Board of Chinese Journal of Cardiology. (2018). Chinese guidelines for the diagnosis and treatment of heart failure 2018. Zhonghua Xin Xue Guan Bing Za Zhi, 46(10), 760–789.Google Scholar
- 22.Melman, Y. F., Shah, R., Danielson, K., Xiao, J., Simonson, B., Barth, A., et al. (2015). Circulating microRNA-30d is associated with response to cardiac resynchronization therapy in heart failure and regulates cardiomyocyte apoptosis: a translational pilot study. Circulation, 131(25), 2202–2216.CrossRefPubMedPubMedCentralGoogle Scholar
- 23.Li, X., Zhang, J., Huang, J., Ma, A., Yang, J., Li, W., et al. (2013). A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure. Journal of the American College of Cardiology, 62(12), 1065–1072.CrossRefPubMedGoogle Scholar
- 24.Wang, Y., Han, X., Fu, M., Wang, J., Song, Y., Liu, Y., et al. (2018). Qiliqiangxin attenuates hypoxia-induced injury in primary rat cardiac microvascular endothelial cells via promoting HIF-1alpha-dependent glycolysis. Journal of Cellular and Molecular Medicine, 22(5), 2791–2803.CrossRefPubMedPubMedCentralGoogle Scholar
- 29.Salmoirago-Blotcher, E., Wayne, P. M., Dunsiger, S., Krol, J., Breault, C., Bock, B. C., et al. (2017). Tai Chi is a promising exercise option for patients with coronary heart disease declining cardiac rehabilitation. Journal of the American Heart Association, 6(10).Google Scholar